This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility: In the fight to find better treatments for bacterial infections, one rapidly evolving therapy uses a group of viruses called bacteriophages (phages). Phages can attack and kill dangerous bacteria while leaving human cells unharmed and bypassing antibiotic resistance.
But bacteria have their own defenses against viruses, and learning how those defenses work can help researchers develop better disease-fighting viruses. Now, new research has revealed that bacteria detect viruses when a viral enzyme cuts an important sensor molecule in the bacterium, triggering an immune response. The discovery paves the way for better phage therapies that can evade the bacterial immune system.
"This is one of the most common forms of bacterial immunity, so when we finally figured it out, it was a total eureka moment," says Sam Hobbs, Ph.D., assistant professor of biochemistry at University of Utah Health and the first author of a paper describing the research. One part of the bacterial immune system, called CBASS, leads to a "last resort" response that kills the bacterium before viruses can spread to its neighbors. With such a dire consequence for the bacterium, precise sensing of the viral trigger is essential.
The sensing mechanism detects a molecule that the virus needs to survive, Hobbs found. "Certain kinds of phages have a protein called a protease, which degrades other proteins," he explains. "We found that the protease from the phage actually acts directly on the host protein, and that is the signal that turns on the whole signaling pathway." It's a very different trigger from those in related antiviral immune pathways, which are activated by the presence of viral genetic material.
"This is a totally new mechanism for how these host proteins are activated," Hobbs says. "I never would have guessed that this was the way it was going to work." Hobbs adds that understanding CBASS may also advance our knowledge of the human immune system. CBASS is related to a similar immune pathway in humans, indicating that this pathway has persisted at least since bacteria and humans had a common ancestor.
And because bacteria have such a rapid life cycle, scientists can use them to quickly answer questions about how the immune system works, which they can then test in models closer to people. "The fact that these systems are conserved between bacteria and humans suggests that they've been maintained in these different organisms for that entire evolutionary trajectory," Hobbs says. "The cells are telling us that this is a really important pathway because they've maintained it for billions of years.
Extract — continue reading at the source.
